NeoGenomics (NEO) Stock: Buy, Sell, or Hold?
NEO - NeoGenomics, Inc.
$16.59
0.20 (1.22%)
▲
5d:
-0.36%
30d:
-15.18%
90d:
+26.26%
BUY
HIGH Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 28, 2026
3d
Get Alerted When NEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NEO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.68
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.36
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEO is currently trading at $16.59, which is considered slightly low relative to its 30-day fair value range of $16.53 to $19.13. From a valuation perspective, the stock is trading at a premium (Forward PE: 48.4) compared to its historical average (43.9). At these levels, the market is pricing in 3.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NEO is in a strong uptrend. Immediate support is located at $15.86, while resistance sits at $17.45.
Market Sentiment: NEO scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.85 (+31.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEO is in a strong uptrend. Immediate support is located at $15.86, while resistance sits at $17.45.
Market Sentiment: NEO scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.85 (+31.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$16.53 -
$19.13
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
91.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (83/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.7% below Wall St target ($21.85)
- NEUTRAL: Market pricing in 3.3% annual earnings growth - fairly valued
- BULLISH: Bottoming setup score 83/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$16.53 -
$19.13
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$15.86
Resistance Level
$17.45
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
48.41
Wall Street Target
$21.85
(+31.7%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
130.6%
Profit Margin
-6.8%
Valuation Premium vs History
+3.3% premium
PE vs Historical
48.4 vs 43.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.3%
(market-implied from PE analysis)
1-Year Target
$17.14
(+3%)
2-Year Target
$17.70
(+7%)
3-Year Target
$18.29
(+10%)
3-Yr Target (if PE normalizes)
(PE: 48→44)
PE COMPRESSION
$16.58
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 48.4, Growth: 83.0%)
$55.99
(+238%)
Base:
(SPY PE: 19.9, Growth: 83.0%)
$22.97
(+39%)
Bear:
(PE: 16.9, Growth: 83.0%)
$19.52
(+18%)
Share & Embed Analysis
Last updated: October 24, 2026 12:18 AM ET
Data refreshes hourly during market hours. Next update: 1:18 AM
Data refreshes hourly during market hours. Next update: 1:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
Advanced NEO Option Strategies
Professional options setups generated by AI based on today's NEO price and gamma walls.
